14-day Premium Trial Subscription Try For FreeTry Free
$6.88
+0.180 (+2.69%)
At Close: May 03, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $141.16 $183.01 Friday, 3rd May 2024 TTNP stock ended at $6.88. This is 2.69% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 1.03% from a day low at $6.81 to a day high of $6.88.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Titan Pharmaceuticals prices

Date Open High Low Close Volume
Mar 14, 2016 $22.56 $23.10 $22.26 $22.74 11 467
Mar 11, 2016 $21.00 $22.32 $20.76 $22.26 18 683
Mar 10, 2016 $22.02 $22.38 $20.70 $21.30 34 000
Mar 09, 2016 $21.90 $21.96 $21.24 $21.48 18 517
Mar 08, 2016 $22.50 $23.34 $21.60 $21.90 13 600
Mar 07, 2016 $21.96 $22.50 $21.48 $22.38 6 850
Mar 04, 2016 $21.72 $22.44 $21.24 $21.72 13 150
Mar 03, 2016 $22.62 $22.62 $21.60 $21.78 16 483
Mar 02, 2016 $22.08 $22.56 $21.48 $22.44 17 350
Mar 01, 2016 $22.86 $23.64 $21.36 $22.20 13 350
Feb 29, 2016 $23.10 $23.22 $21.78 $22.92 24 067
Feb 26, 2016 $23.28 $23.88 $22.80 $23.04 26 567
Feb 25, 2016 $23.82 $23.88 $22.68 $23.28 25 733
Feb 24, 2016 $21.00 $24.60 $20.82 $23.94 66 783
Feb 23, 2016 $21.12 $21.60 $20.70 $21.30 10 950
Feb 22, 2016 $19.50 $22.14 $19.44 $21.00 108 533
Feb 19, 2016 $25.20 $25.80 $18.30 $20.46 154 833
Feb 18, 2016 $23.70 $25.86 $23.40 $24.78 84 817
Feb 17, 2016 $22.32 $23.04 $21.36 $23.04 35 550
Feb 16, 2016 $23.22 $23.46 $20.82 $21.24 47 400
Feb 12, 2016 $20.70 $21.54 $20.04 $20.64 28 650
Feb 11, 2016 $20.10 $21.90 $19.92 $20.76 19 683
Feb 10, 2016 $20.88 $22.62 $20.34 $20.40 46 100
Feb 09, 2016 $20.82 $22.26 $20.46 $20.70 10 283
Feb 08, 2016 $22.74 $23.88 $20.70 $20.76 28 533
Click to get the best stock tips daily for free!

About Titan Pharmaceuticals

Titan Pharmaceuticals Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and the European Union. It is also developing kappa opioid agonist peptide program (TP-2021) for use in combination... TTNP Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT